Fig. 3From: Yeast display platform technology to prepare oral vaccine against lethal H7N9 virus challenge in miceImmune protection conferred by S.cerevisiae EBY100/pYD5-HA against lethal H7N9 virus challenge. Mice were intranasally challenged with a lethal dose (10 × LD50) of A/Anhui/1/2013 (AH-H7N9) virus at 2 weeks after the final immunization (n = 10/group). a Weight change as a percentage. Bars indicate SDs. b Lung viral titers were determined by a plaque assay at day 3 after challenge (n = 3 of 10 challenged mice). c Survival rate. Asterisk indicates significant difference compared to S.cerevisiae EBY100/pYD5 and PBS groups (p < 0.05)Back to article page